Blair William & Co. IL Sells 26,650 Shares of Haleon PLC Sponsored ADR (NYSE:HLN)

Blair William & Co. IL cut its stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 68.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,295 shares of the company's stock after selling 26,650 shares during the quarter. Blair William & Co. IL's holdings in Haleon were worth $127,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Bartlett & CO. Wealth Management LLC increased its position in Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after buying an additional 1,491 shares during the last quarter. Opal Wealth Advisors LLC acquired a new position in Haleon during the first quarter worth $29,000. Continuum Advisory LLC increased its position in Haleon by 152.4% during the first quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock worth $49,000 after buying an additional 2,870 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in Haleon during the first quarter worth $56,000. Finally, Cullen Frost Bankers Inc. increased its position in Haleon by 99.5% during the first quarter. Cullen Frost Bankers Inc. now owns 6,291 shares of the company's stock worth $65,000 after buying an additional 3,137 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HLN has been the topic of several analyst reports. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price on the stock in a research report on Friday, May 9th. Barclays reaffirmed an "overweight" rating on shares of Haleon in a research report on Tuesday, May 6th. BNP Paribas raised Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Wall Street Zen downgraded Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Finally, BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research report on Tuesday, May 27th. Five analysts have rated the stock with a hold rating, three have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Stock Performance

Shares of NYSE HLN traded down $0.06 during mid-day trading on Friday, hitting $9.64. The company had a trading volume of 7,875,929 shares, compared to its average volume of 11,052,347. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The business's 50-day simple moving average is $10.04 and its 200-day simple moving average is $10.20. Haleon PLC Sponsored ADR has a 12 month low of $8.86 and a 12 month high of $11.42. The firm has a market cap of $43.30 billion, a P/E ratio of 24.72, a PEG ratio of 2.86 and a beta of 0.23.

Haleon Increases Dividend

The business also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be paid a $0.0555 dividend. The ex-dividend date is Friday, August 15th. This is a boost from Haleon's previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. Haleon's dividend payout ratio is 64.10%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.